TNYA vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

TNYA

58.5
AI Score
VS
TNYA Wins

CBIO

45.7
AI Score

Investment Advisor Scores

TNYA

59score
Recommendation
HOLD

CBIO

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric TNYA CBIO Winner
Revenue 225,000 1.04M CBIO
Net Income -19.27M -48.12M TNYA
Net Margin -8565.3% -4631.4% CBIO
Operating Income -20.07M -51.09M TNYA
ROE -18.1% -29.5% TNYA
ROA -14.3% -26.3% TNYA
Total Assets 135.07M 182.76M CBIO
Cash 80.89M 171.59M CBIO
Current Ratio 5.75 9.66 CBIO
Free Cash Flow -19.25M -28.56M TNYA

Relative Price Performance (Last 90 Days)

TNYA 1M: -0.8% · 3M: +7.1% CBIO 1M: -15.3% · 3M: -35.3%

Current Technical Phase

TNYA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.6 · Price: $0.74

CBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.7%), weak momentum, RSI 39

RSI (14): 38.5 · Price: $14.47

Fundamentals Snapshot

Metric TNYA CBIO
Market Cap
Forward P/E -1.8 -4.9
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 1.0% 1.0%
Operating Margin -89.2% -23.8%
EPS -0.45 -5.97
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, TNYA is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.